Mealeys

Recent Posts

Pfizer Shareholder Class OK'd By MDL Judge For Disclosures About Celebrex, Bextra
Posted on 3 Apr 2012 by Mealeys

NEW YORK - A New York federal judge overseeing the Pfizer Inc. securities multidistrict litigation on March 29 certified a class of shareholders who allege that their stock value was affected by misstatements and omissions concerning the safety of the... Read More

Judge Approves Stipulation And Settlement Of Shareholder Derivative Suit
Posted on 4 Dec 2012 by Mealeys

GRAND RAPIDS, Mich. - A federal judge in Michigan on Nov. 29 approved a settlement between a group of shareholders and directors and officers of a corporation that puts in place certain corporate governance measures (Westchester Putnam Counties Heavy... Read More

Judge Appoints Pension Fund Lead Plaintiff In Drug Company Shareholder Suit
Posted on 17 Apr 2012 by Mealeys

CHICAGO - Finding that a pension fund's pleadings were superior to those of other movants, a federal judge in Illinois on April 13 appointed the pension fund as lead plaintiff in a shareholder derivative lawsuit against a drug company that allegedly... Read More

Judge Grants Final Approval Of $688M Settlement In 2 Securities Class Actions
Posted on 2 Oct 2013 by Mealeys

NEWARK, N.J. - A federal judge in New Jersey on Oct. 1 granted final approval of a $688 million settlement in two securities class action lawsuits alleging that Merck and Co. Inc. and others failed to disclose adverse results of a clinical trial for two... Read More

Genzyme Shareholder Class Dismissed For Lack Of Scienter By Mass. Federal Judge
Posted on 3 Apr 2012 by Mealeys

BOSTON - A Massachusetts federal judge on March 30 dismissed a purported class action by shareholders of Genzyme Corp., finding that the plaintiffs failed to show scienter that the company and its executives failed to disclose problems at manufacturing... Read More

Medical Device Manufacturer To Pay $30M For Role In Securities Fraud Scheme
Posted on 8 Jan 2014 by Mealeys

WASHINGTON, D.C. - Medical device manufacturer ArthroCare Corp. will pay a $30 million monetary penalty to settle claims that certain of its senior executives engaged in a securities fraud scheme that bilked the company's shareholders out of more... Read More

Medtronic Agrees To Settle Infuse Shareholder Class For $85M, Denies Liability
Posted on 3 Apr 2012 by Mealeys

MINNEAPOLIS - Medtronic Inc. on March 30 said in a press release that it has agreed in principle to settle a stockholder class action involving its Infuse Bone Graft product for $85 million (Minneapolis Firefighters' Relief Association, et al. v.... Read More